Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Isis sublicenses technology for designing improved antisense drugs

Dec. 2, 1998

Novel injectable drug delivery technology in-licensed by Medi-Ject

Dec. 2, 1998

Jenner Biotherapies receives patent on improved vaccine formulation

Dec. 1, 1998

Transkaryotic Therapies extends agreement with PolyMASC to include second drug candidate

Nov. 30, 1998

Inex receives patent protection for vital component of TCS delivery system

Nov. 30, 1998

Cell Genesys describes improved vectors for gene therapy

Nov. 27, 1998

Pharmacopeia achieves milestone in collaboration with Schering-Plough

Nov. 26, 1998

GeneMedicine expands collaboration with Merck for GeneSwitch technology

Nov. 25, 1998

AVI BioPharma presents advantages of CytoPorter drug delivery engine

Nov. 25, 1998

Supratek, RPR Gencell work together to improve delivery of cardiovascular gene therapy

Nov. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...